Cite

HARVARD Citation

    Cornec, D. et al. (2016). Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome. Journal of autoimmunity. pp. 102-110. [Online]. 
  
Back to record